PACLIEVA 30MG is an Injection medication used for treatment purposes. It is manufactured by Allieva Pharma Private Limited.
| Brand Name | PACLIEVA 30MG |
|---|---|
| Composition | Paclitaxel Injection 30mg |
| Manufacturer | Allieva Pharma Private Limited |
| Dosage Form | Injection |
| Packaging | Vial |
| Country of Origin | India |
Paclitaxel Injection 30mg (Paclitaxel Injection 30mg) is a widely used Injection medicine manufactured by Allieva Pharma Private Limited. It is commonly prescribed for...
Paclieva contains Paclitaxel, a chemotherapy (anticancer) medicine belonging to the taxane group. It works by stabilizing microtubules and inhibiting their breakdown, which prevents cancer cell division and leads to cell death.
Paclitaxel Injection is used in the treatment of:
Breast cancer
Ovarian cancer
Non-small cell lung cancer (NSCLC)
Kaposi’s sarcoma (AIDS-related)
Head & neck cancers (in combination regimens)
Common side effects:
Hair loss (alopecia)
Nausea and vomiting
Low blood counts (anemia, neutropenia, thrombocytopenia)
Fatigue, weakness
Muscle and joint pain
Peripheral neuropathy (tingling, numbness)
Dosage depends on body surface area (BSA), cancer type, and regimen.
Common dosing schedules:
175 mg/m² IV over 3 hours every 3 weeks
135 mg/m² IV over 24 hours every 3 weeks
Weekly regimen: 80–100 mg/m² IV
NOTE: This medicine should be taken only under a doctor’s supervision.